Med Axia Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Kushinagar, Uttar Pradesh, India, established in 2015.
2015 Kushinagar, Uttar Pradesh, India Struck Off
Last Updated:
About Med Axia Pharmaceuticals Private Limited

Med Axia Pharmaceuticals Private Limited, a struck off private limited company, was established on 12 May 2015 in Kushinagar, Uttar Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24233UP2015PTC070631. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a active non-compliant status. Its leadership includes Yogeshwar Kumar Madheshia (Director), Bhawna Gupta (Director). It is based at Dashrath Pd Gorakhpur Road, Kasia, Kushinagar, Uttar Pradesh, 274402.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233UP2015PTC070631

  • Registration Number

    070631

  • Incorporation Date

    12 May 2015

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 10 Year, 9 Months
Company report

Med Axia Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Med Axia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Med Axia Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Yogeshwar Kumar Madheshia Director 12 May 2015 Current
Bhawna Gupta Director 12 May 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Med Axia Pharmaceuticals.

Enhance accessibility to Med Axia Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Med Axia Pharmaceuticals revenue growth over time
Med Axia Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Med Axia Pharmaceuticals?

Unlock access to Med Axia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Med Axia Pharmaceuticals?

Unlock and access historical data on people associated with Med Axia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Med Axia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Med Axia Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Med Axia Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Yogeshwar Kumar Madheshia was appointed as a Director was appointed as a Director on 12 May 2015 & has been associated with this company since 10 years 9 months . was completed.

  • Director Appointment

    Progress on Bhawna Gupta was appointed as a Director was appointed as a Director on 12 May 2015 & has been associated with this company since 10 years 9 months . was documented.

  • Company Incorporation

    The activity Med Axia Pharmaceuticals Private Limited was registered on 12 May 2015 with Roc Kanpur & aged 10 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Med Axia Pharmaceuticals Private Limited?

The CIN of Med Axia Pharmaceuticals Private Limited is U24233UP2015PTC070631.

Where is Med Axia Pharmaceuticals Private Limited headquartered?

Med Axia Pharmaceuticals Private Limited is headquartered at Dashrath Pd Gorakhpur Road, Kasia, Kushinagar, Uttar Pradesh, 274402.

When was Med Axia Pharmaceuticals Private Limited incorporated?

Med Axia Pharmaceuticals Private Limited was incorporated on 12 May 2015.

Who are the current directors of Med Axia Pharmaceuticals Private Limited?

The current directors of Med Axia Pharmaceuticals Private Limited are

What is the primary industry of Med Axia Pharmaceuticals Private Limited?

The primary industry of Med Axia Pharmaceuticals Private Limited is Chemicals.

Is Med Axia Pharmaceuticals Private Limited a listed company?

Med Axia Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Med Axia Pharmaceuticals Private Limited?

The authorized capital of Med Axia Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Med Axia Pharmaceuticals Private Limited?

The compliance status of Med Axia Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available